BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,303 | +67020.9% | 9,017 | -19.0% | 0.02% | -28.6% |
| Q2 2023 | $507 | -54.2% | 11,134 | -59.2% | 0.02% | -56.2% |
| Q1 2023 | $1,108 | -75.8% | 27,316 | -69.6% | 0.05% | -76.5% |
| Q4 2022 | $4,572 | -99.2% | 89,709 | +753.2% | 0.20% | +436.8% |
| Q3 2022 | $566,000 | -17.0% | 10,514 | -1.0% | 0.04% | +26.7% |
| Q2 2022 | $682,000 | -28.2% | 10,622 | -13.3% | 0.03% | -16.7% |
| Q1 2022 | $950,000 | -12.7% | 12,250 | -3.3% | 0.04% | -7.7% |
| Q4 2021 | $1,088,000 | +2.8% | 12,667 | -3.7% | 0.04% | -4.9% |
| Q3 2021 | $1,058,000 | +4.3% | 13,154 | +4.4% | 0.04% | +7.9% |
| Q2 2021 | $1,014,000 | -13.7% | 12,594 | -9.6% | 0.04% | -17.4% |
| Q1 2021 | $1,175,000 | +3.7% | 13,931 | -1.2% | 0.05% | -11.5% |
| Q3 2020 | $1,133,000 | -9.8% | 14,094 | -3.4% | 0.05% | -16.1% |
| Q2 2020 | $1,256,000 | +4.9% | 14,589 | -1.0% | 0.06% | -10.1% |
| Q1 2020 | $1,197,000 | -3.2% | 14,740 | -0.4% | 0.07% | +21.1% |
| Q4 2019 | $1,237,000 | -9.3% | 14,795 | -5.1% | 0.06% | -16.2% |
| Q3 2019 | $1,364,000 | +2.1% | 15,587 | -4.4% | 0.07% | +4.6% |
| Q2 2019 | $1,336,000 | +0.8% | 16,309 | 0.0% | 0.06% | -1.5% |
| Q1 2019 | $1,326,000 | +29.9% | 16,309 | +5.2% | 0.07% | +8.2% |
| Q4 2018 | $1,021,000 | -15.6% | 15,507 | -1.1% | 0.06% | +1.7% |
| Q3 2018 | $1,210,000 | +2.3% | 15,687 | -2.1% | 0.06% | -1.6% |
| Q2 2018 | $1,183,000 | +12.1% | 16,020 | -1.2% | 0.06% | +13.0% |
| Q1 2018 | $1,055,000 | +1.2% | 16,220 | +0.6% | 0.05% | -23.9% |
| Q4 2017 | $1,042,000 | -10.7% | 16,120 | -13.3% | 0.07% | +16.4% |
| Q3 2017 | $1,167,000 | +2.1% | 18,597 | -1.5% | 0.06% | -1.6% |
| Q2 2017 | $1,143,000 | +11.4% | 18,878 | -4.6% | 0.06% | +8.8% |
| Q1 2017 | $1,026,000 | +16.9% | 19,788 | 0.0% | 0.06% | +14.0% |
| Q4 2016 | $878,000 | -6.8% | 19,788 | 0.0% | 0.05% | -10.7% |
| Q3 2016 | $942,000 | +5.3% | 19,788 | 0.0% | 0.06% | +5.7% |
| Q2 2016 | $895,000 | +0.6% | 19,788 | -8.6% | 0.05% | 0.0% |
| Q1 2016 | $890,000 | +11.4% | 21,658 | +3.4% | 0.05% | +12.8% |
| Q4 2015 | $799,000 | +7.5% | 20,938 | -7.3% | 0.05% | +4.4% |
| Q3 2015 | $743,000 | -77.7% | 22,598 | -52.5% | 0.04% | -75.7% |
| Q2 2015 | $3,329,000 | +1.2% | 47,598 | -0.9% | 0.18% | +2.2% |
| Q1 2015 | $3,290,000 | -9.3% | 48,029 | -2.9% | 0.18% | -8.6% |
| Q4 2014 | $3,626,000 | -4.3% | 49,463 | -6.3% | 0.20% | -7.0% |
| Q3 2014 | $3,788,000 | +8.4% | 52,784 | +9.2% | 0.21% | +9.2% |
| Q2 2014 | $3,493,000 | -1.2% | 48,316 | +0.6% | 0.20% | -3.0% |
| Q1 2014 | $3,535,000 | +4.6% | 48,042 | -1.1% | 0.20% | +4.7% |
| Q4 2013 | $3,379,000 | +5.5% | 48,577 | -0.4% | 0.19% | -3.0% |
| Q3 2013 | $3,202,000 | -2.0% | 48,748 | +3.4% | 0.20% | -7.0% |
| Q2 2013 | $3,266,000 | – | 47,148 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |